Insight Molecular Diagnostics (IMDX) Free Cash Flow Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Free Cash Flow Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -117.95% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 126.04% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 2.94% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 24.06% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 87.85% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 15.26% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -20.33% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 20.67% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -30.93% |
| 10 | Insight Molecular Diagnostics | 4.44 Mn | -24.49 Mn | 15,000.00 | -34.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.27% |
| Dec 31, 2025 | -26.22% |
| Sep 30, 2025 | 1.16% |
| Jun 30, 2025 | -7.75% |
| Mar 31, 2025 | -59.47% |
| Dec 31, 2024 | -18.71% |
| Sep 30, 2024 | -75.26% |
| Jun 30, 2024 | 9.70% |
| Mar 31, 2024 | 53.57% |
| Dec 31, 2023 | 55.14% |
| Sep 30, 2023 | 73.85% |
| Jun 30, 2023 | 44.75% |
| Mar 31, 2023 | 44.06% |
| Dec 31, 2022 | -39.97% |
| Sep 30, 2022 | -7.72% |
| Jun 30, 2022 | -42.65% |
| Mar 31, 2022 | -38.97% |
| Dec 31, 2021 | -18.32% |
| Sep 30, 2021 | -74.20% |
| Jun 30, 2021 | -16.32% |